<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Danish Thorotrast Study was recently reestablished and improved </plain></SENT>
<SENT sid="1" pm="."><plain>The cohort has been reidentified and followed up, and now comprises 1003 Thorotrast-exposed patients </plain></SENT>
<SENT sid="2" pm="."><plain>For <z:hpo ids='HP_0000001'>all</z:hpo> suspected haematological cases, cytological and histological material has been revised and malignant diseases have been reclassified </plain></SENT>
<SENT sid="3" pm="."><plain>The numbers of cases of <z:hpo ids='HP_0001909'>leukemia</z:hpo> and other related <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> were as follows: 16 <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>); 8 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>); 1 <z:hpo ids='HP_0006721'>acute lymphatic leukemia</z:hpo> (ALL); 3 <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>); 4 non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL); 2 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM); 2 <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (MF); 2 <z:hpo ids='HP_0005550'>chronic lymphatic leukemia</z:hpo> (CLL) </plain></SENT>
<SENT sid="4" pm="."><plain>Except for CLL, <z:hpo ids='HP_0000001'>all</z:hpo> cases might be Thorotrast-induced </plain></SENT>
<SENT sid="5" pm="."><plain>(Expected number of <z:hpo ids='HP_0001909'>leukemias</z:hpo>: &lt; 2.5.) The findings in the German, Japanese, Portuguese and Danish studies are very similar </plain></SENT>
<SENT sid="6" pm="."><plain>Some of the characteristic features include a high incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with several <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemias</z:e>, many cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and a relatively low incidence of <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>In several studies of <z:hpo ids='HP_0001909'>leukemia</z:hpo> induced by <z:chebi fb="0" ids="22333">alkylating agents</z:chebi>, <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> is also described as a prominent feature </plain></SENT>
<SENT sid="8" pm="."><plain>The possibility exists that a phase of relative predominance of erythroid elements in the bone marrow may be a common and not an unusual feature in the pathogenesis of these secondary <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The findings are also compared with histopathological data from a Danish control group of de novo <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients and from atomic bomb survivors with radiation-induced <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The relative frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> is higher among the Thorotrast-exposed patients than among the Danish control group and the A-bomb survivors </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, low relative frequencies are seen for ALL and <z:mp ids='MP_0005481'>CML</z:mp> in Thorotrast cases in comparison with de novo <z:hpo ids='HP_0001909'>leukemia</z:hpo> cases and A-bomb survivors </plain></SENT>
<SENT sid="12" pm="."><plain>It can be concluded that differences in relative and absolute frequency of <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> exist not only between the irradiated populations and the unexposed control group, but even between groups exposed to low-LET (linear energy transfer) and high-LET radiation </plain></SENT>
</text></document>